Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic Alopecia (AGA) greatly lowers quality of life, causing stress and low self-esteem, with those seeking treatment experiencing more impairment.

Phyllotex™ extract was found to significantly promote hair growth and protect against hair loss.

Minoxidil base is preferred for hair loss treatment, but minoxidil sulfate may be an alternative for unresponsive patients.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

LLLT is a safe, promising hair loss treatment, but more research needed.

Dermoscopy is useful for diagnosing different types of hair loss.

New understanding and treatments for hair loss are improving, but more research is needed.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Various treatments exist for hair loss, but more research is needed for better options.

Hair length and thickness are related, with thickness peaking at about a quarter of the hair's maximum length.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Use antiandrogens and other treatments for hair loss.

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.

Spironolactone can effectively treat hair loss with manageable side effects.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

Higher NLR, PLR, and MPV may help diagnose androgenetic alopecia.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Hair thickness differences help diagnose hair loss severity.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Microneedling may help hair loss, but needs more research.

RF-mesotherapy with dutasteride may be a promising alternative treatment for hair loss.

ECM changes may play a role in hair loss, with differences between males and females.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The treatments for fungal nail infection, hair loss in men, benign nail tumor, and chemotherapy-associated nail bed inflammation are effective and safe.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.